StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Financials through fiscal 2025, year ended Dec 31, 2025Score 7/30
$34.39−0.40 (-1.15%)

Close on Nov 17, 2026Market cap $2.27BP/E 6.4Yield –

Lakefront Biotherapeutics total assets

Total assets on the balance sheet at the end of each period.

Lakefront Biotherapeutics's total assets was €3.41B at Dec 31, 2025. For fiscal 2025 it was €3.41B, down 17.6% from the year before. Over ten years it grew 22.6% a year on average. The highest annual figure on record is €6.07B in fiscal 2019.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025€3.41B-17.6%
FY2024Dec 31, 2024€4.14B-5.1%
FY2023Dec 31, 2023€4.36B-8.0%
FY2022Dec 31, 2022€4.73B-8.8%
FY2021Dec 31, 2021€5.19B-9.2%
FY2020Dec 31, 2020€5.72B-5.8%
FY2019Dec 31, 2019€6.07B+321.6%
FY2018Dec 31, 2018€1.44B+11.9%
FY2017Dec 31, 2017€1.29B+18.7%
FY2016Dec 31, 2016€1.08B+144.8%
FY2015Dec 31, 2015€442.51M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025€3.41B-34.4%
Q4 FY2024Dec 31, 2024€4.14B-23.8%
Q4 FY2023Dec 31, 2023€4.36B-23.8%
Q4 FY2022Dec 31, 2022€4.73B-19.1%
Q4 FY2021Dec 31, 2021€5.19B-14.4%
Q2 FY2021Jun 30, 2021€5.43B+299.9%
Q4 FY2020Dec 31, 2020€5.72B+297.2%
Q2 FY2020Jun 30, 2020€5.85B+385.9%
Q4 FY2019Dec 31, 2019€6.07B+371.8%
Q2 FY2019Jun 30, 2019€1.36B+25.3%
Q4 FY2018Dec 31, 2018€1.44B+225.3%
Q2 FY2018Jun 30, 2018€1.20B–
Q4 FY2017Dec 31, 2017€1.29B–
Q4 FY2016Dec 31, 2016€1.08B–
Q4 FY2015Dec 31, 2015€442.51M–

More Lakefront Biotherapeutics figures

See a number that looks wrong?